Home / Inspections / 1020609

FDA Inspection 1020609 — Shilpa Medicare Limited

Shilpa Medicare Limited — FEI 3009876430

The FDA completed an inspection of Shilpa Medicare Limited on July 28, 2017 in Jadcherla, Mahabubnagar District. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 28, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jadcherla, Mahabubnagar District (India)

Facility

Other inspections at this facility

  • 1121634 (OAI Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1101543 (VAI Fri Sep 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1036712 (VAI Thu Nov 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983085 (NAI Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 939599 (VAI Wed Aug 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources